1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Triphase Acquires Nereus Pharmaceuticals

M&A Deal Summary

Triphase Acquires Nereus Pharmaceuticals

On January 2, 2012, Triphase acquired life science company Nereus Pharmaceuticals

Acquisition Highlights
  • This is Triphase’s 1st transaction in the Life Science sector.
  • This is Triphase’s 1st transaction in the United States.
  • This is Triphase’s 1st transaction in California.

M&A Deal Summary
Date 2012-01-02
Target Nereus Pharmaceuticals
Sector Life Science
Buyer(s) Triphase
Deal Type Add-on Acquisition

Target

Nereus Pharmaceuticals

San Diego, California, United States
Nereus Pharmaceuticals is a pioneer in the use of marine microbial sources for the discovery and follow-on development of new therapeutics for cancer and inflammatory and infectious diseases.

Search 215,074 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Triphase

Toronto, Ontario, Canada
Category Company
Founded 2010
Sector Life Science
DESCRIPTION

Triphase acquires promising cancer therapies and accelerates their development from pre-IND to clinical proof-of-concept leveraging our deep relationships with world-class scientists, clinicians, and business professionals with access to state-of-the-art facilities and capabilities. Triphase was founded in 2010 and is based in Toronto, Ontario.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2012 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal